3 hrs ago | Myrtle Beach Online
NC school board member dies following assault
The family of a longtime member of North Carolina's state school board says she has died from the injuries she suffered in a weekend assault.
8 hrs ago | Palm Beach Post
Tenn. federal judge won't dismiss jaw injury cases
U.S. District Judge Todd Campbell's ruling last week was the latest blow to Novartis Corp., which is facing lawsuits from hundreds of patients around the country over its bone-strengthening drugs Aredia and Zometa.
12 hrs ago | WWUP-TV Cadillac
3/8/2010 - Blue Cross scraps plan to buy Lansing-based HMO
Blue Care Network announced Sept. 15 it planned to buy the membership of Physicians Health Plan of Mid-Michigan. Sparrow Health System owns the Lansing-based HMO, which has about 80,000 members.
16 hrs ago | Fort Worth Star-Telegram
Merck, Sanofi combining animal medicine businesses
Two of the world's biggest pharmaceutical companies said Tuesday they are uniting their animal health businesses in a deal to become the top dog in the veterinary industry.
Cell Therapeutics: FDA OKs production site
Cell Therapeutics said Monday that the U.S. Food and Drug Administration completed its inspection of the facility in Italy that manufactures the company's pixantrone drug and "found the site in compliance and acceptable for continued manufacturing of the drug product." Pixantrone is under review by the FDA to treat relapsed/refractory aggressive ...
Roche Suspends Arthritis Drug Study After Deaths
Swiss pharmaceutical company Roche Group said Monday it has suspended a late-stage trial for a new rheumatoid arthritis and lupus drug after several patients died from infections.
A tipple a day keeps obesity at bay in women: Study
Women who drink a couple of glasses of red wine, beer or spirits a day are better at keeping the pounds off than women who do not drink at all, according to a study published Monday.
Court to decide if drugmakers can be sued over vaccines
The Supreme Court will decide whether drug makers can be sued by parents who claim their children suffered serious health problems from vaccines.
Astra's Colon Cancer Drug Fails Test
AstraZeneca PLC said Monday that its cancer drug Recentin failed in a head to head late stage trial with Roche AG's Avastin in tests for use as an initial treatment against colon cancer.
Isis Pharmaceuticals 4Q loss widens on costs
Biotechnology company Isis Pharmaceuticals Inc. said Monday its fourth-quarter loss widened on a boost in research and development costs.
Takeover: Arrow Energy gets $3.3bn offer
ARROW Energy has received a conditional $3.3 billion takeover offer from a company jointly owned by Royal Dutch Shell and PetroChina.
Foggy U.S. 41 crashes near Kaukauna create danger, fear
A few minutes after dropping his daughter off at a Little Chute day care Friday morning, Jeff Malloy found himself parked precariously on the side of fog-shrouded U.S. 41 fearing for his life.
State school board member found injured in Raleigh home
Paramedics transported Kathy A. Taft, a member of the state Board of Education, to WakeMed on Saturday morning after she was found with serious injuries at a Raleigh home.
FDA reviewing InterMune's IPF drug
BRISBANE,A Calif. The Food and Drug Administration is reviewing a drug for treating a lung condition that affects around 200,000 people in the United States and Europe.
China goes shopping for U.S. investments
In the past year, Chinese acquisitions in the U.S. have ranged from a relatively obscure theater in Branson, Mo., to stakes in such famous brands as Coca-Cola and Johnson & Johnson.
UCSD, Black Student Union agree on plan for diversity programs
A UCSD student walks past a poster on campus on Thursday that raises issues about diversity on campus.
HealthTronics 4th-qtr loss narrows as charges fall
Medical equipment maker HealthTronics Inc. reported a narrower fourth-quarter loss compared to a year earlier, when it absorbed $144 million in impairment charges.
Street Cheers Prospects For InterMune Drug
Biotech's shares soar after unexpectedly supportive report on lung disease drug.
Drugmakers boost consumer ad spending 2 pct in '09
Drugmakers spent a combined $4.51 billion on ads for prescription medicines aimed at consumers.
Intermune shares surge as FDA reviews lung drug
Shares of drug developer InterMune Inc. surged Friday after federal health officials posted their review of the experimental drug pirfenidone, which is designed to treat a rare lung disease.
Also on Topix